Patents by Inventor Seung Chu

Seung Chu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180282432
    Abstract: The present invention is directed to novel heterodimeric antibodies.
    Type: Application
    Filed: April 4, 2018
    Publication date: October 4, 2018
    Inventors: Matthew J. Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal, Sung-Hyung Lee
  • Publication number: 20180223000
    Abstract: The present invention is directed to novel heterodimeric antibodies.
    Type: Application
    Filed: April 4, 2018
    Publication date: August 9, 2018
    Inventors: Matthew J. Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal, Sung-Hyung Lee
  • Patent number: 9856327
    Abstract: The present invention is directed to novel heterodimeric antibodies.
    Type: Grant
    Filed: June 17, 2016
    Date of Patent: January 2, 2018
    Assignee: Xencor, Inc.
    Inventors: Matthew J. Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal, Sung-Hyung Lee
  • Patent number: 9850320
    Abstract: The present invention is directed to novel heterodimeric antibodies.
    Type: Grant
    Filed: June 17, 2016
    Date of Patent: December 26, 2017
    Assignee: Xencor, Inc.
    Inventors: Matthew J. Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal, Sung-Hyung Lee
  • Patent number: 9822186
    Abstract: The invention provides novel heterodimeric proteins including heterodimeric antibodies.
    Type: Grant
    Filed: March 30, 2015
    Date of Patent: November 21, 2017
    Assignee: XENCOR, INC.
    Inventors: Matthew Bernett, Seung Chu, Gregory Moore, John Desjarlais
  • Publication number: 20170320947
    Abstract: The present invention is directed to heterodimeric antibodies that bind CD3 and PSMA.
    Type: Application
    Filed: December 7, 2016
    Publication date: November 9, 2017
    Inventors: Gregory Moore, John Desjarlais, Seung Chu
  • Publication number: 20170081420
    Abstract: The present invention is directed to novel heterodimeric antibodies.
    Type: Application
    Filed: June 17, 2016
    Publication date: March 23, 2017
    Inventors: Matthew J. Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal, Sung-Hyung Lee
  • Publication number: 20170081424
    Abstract: The present invention is directed to novel heterodimeric antibodies.
    Type: Application
    Filed: June 17, 2016
    Publication date: March 23, 2017
    Inventors: Matthew J. Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal, Sung-Hyung Lee
  • Publication number: 20170037131
    Abstract: The present invention relates to methods and compositions for modulating T cells. The modulation includes suppressing or inducing regulatory T cells or cytotoxic T cells.
    Type: Application
    Filed: March 7, 2016
    Publication date: February 9, 2017
    Inventors: Matthew Bernett, Seung Chu, Dilki Wickramarachichi, John Desjarlais
  • Publication number: 20160355608
    Abstract: The present invention is directed to novel heterodimeric antibodies.
    Type: Application
    Filed: April 28, 2016
    Publication date: December 8, 2016
    Inventors: Matthew J. Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal, Sung-Hyung Lee
  • Publication number: 20160355600
    Abstract: The invention provides trispecific antibodies that co-engage CD3, CD8 and a tumor target antigen.
    Type: Application
    Filed: December 22, 2015
    Publication date: December 8, 2016
    Inventors: Gregory Moore, John Desjarlais, Seung Chu, Sung-Hyung Lee
  • Publication number: 20160229924
    Abstract: The present invention is directed to novel heterodimeric antibodies.
    Type: Application
    Filed: November 25, 2015
    Publication date: August 11, 2016
    Inventors: Matthew J. Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal
  • Publication number: 20160215063
    Abstract: The present invention is directed to heterodimeric antibodies that bind CD3 and CD38.
    Type: Application
    Filed: November 25, 2015
    Publication date: July 28, 2016
    Inventors: Matthew J. Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal
  • Publication number: 20160176969
    Abstract: The invention provides bispecific antibodies that co-engage CD8 (preferably bivalently) and a target tumor antigen.
    Type: Application
    Filed: November 25, 2015
    Publication date: June 23, 2016
    Inventors: Matthew J. Bernett, Gregory Moore, John Desjarlais, Seung Chu, Sung-Hyung Lee
  • Publication number: 20150307629
    Abstract: The invention provides novel heterodimeric proteins including heterodimeric antibodies.
    Type: Application
    Filed: March 30, 2015
    Publication date: October 29, 2015
    Inventors: Matthew Bernett, Seung Chu, Gregory Moore, John Desjarlais
  • Publication number: 20140294836
    Abstract: The present invention provides methods and compositions comprising a heterodimeric antibody comprising a first monomer comprising a first variant heavy chain constant region and an anti-CD4 binding moiety. The heterodimeric antibody also comprises a second monomer comprising: a second variant heavy chain constant region and an anti-CD25 binding moiety. In some cases, the pIs of the first and second variant heavy chain constant regions are at least 0.5 logs apart.
    Type: Application
    Filed: March 14, 2014
    Publication date: October 2, 2014
    Applicant: Xencor, Inc.
    Inventors: Seung Chu, Matthew Bernett, Dilki Wickramarachchi
  • Publication number: 20140294759
    Abstract: The present invention relates to methods and compositions for modulating T cells. The modulation includes suppressing or inducing regulatory T cells or cytotoxic T cells.
    Type: Application
    Filed: March 17, 2014
    Publication date: October 2, 2014
    Inventors: Seung Chu, Matthew Bernett, Dilki Wickramarachchi, John Desjarlais
  • Publication number: 20070166309
    Abstract: An antibody that targets CD30, wherein the antibody comprises at least one modification relative to a parent antibody and the antibody binds with altered affinity to an Fc?R or alters effector function as compared to the parent antibody. Also disclosed are methods of using the anti-CD30 antibody.
    Type: Application
    Filed: March 15, 2007
    Publication date: July 19, 2007
    Applicant: Xencor, Inc.
    Inventors: Gregory Lazar, John Desjarlais, Philip Hammond, David Carmichael, Bao-lu Chen, Seung Chu, Sher Karki
  • Patent number: D629193
    Type: Grant
    Filed: April 1, 2010
    Date of Patent: December 21, 2010
    Assignee: Fattafa Limited
    Inventor: Seung-Chu Liu
  • Patent number: D679271
    Type: Grant
    Filed: April 25, 2012
    Date of Patent: April 2, 2013
    Assignee: Fattafa Limited
    Inventor: Seung Chu Liu